tiprankstipranks
HemoGenyx Pharmaceuticals Plc (GB:HEMO)
LSE:HEMO
UK Market
HEMO
HemoGenyx Pharmaceuticals Plc
RESEARCH TOOLSreports
Want to see GB:HEMO full AI Analyst Report?

HemoGenyx Pharmaceuticals Plc (HEMO) Stock News & Sentiment

37 Followers
Hemogenyx advances lead CAR-T trial and secures funding to complete Phase 1
Premium
Company Announcements
Hemogenyx advances lead CAR-T trial and secures funding to complete Phase 1
6d ago
Hemogenyx Raises £3m to Accelerate HG-CT-1 Trials and Early Commercialisation
Premium
Company Announcements
Hemogenyx Raises £3m to Accelerate HG-CT-1 Trials and Early Commercialisation
8d ago
Hemogenyx Files Annual FDA IND Report as AML CAR‑T Trial Shows Early Promise
Premium
Company Announcements
Hemogenyx Files Annual FDA IND Report as AML CAR‑T Trial Shows Early Promise
22d ago
Hemogenyx Advances HG-CT-1 CAR-T Program With Manufacturing Transfer and Trial Expansion
Premium
Company Announcements
Hemogenyx Advances HG-CT-1 CAR-T Program With Manufacturing Transfer and Trial Expansion
1M ago
Hemogenyx Pharmaceuticals Updates Share Capital and Voting Rights Structure
Premium
Company Announcements
Hemogenyx Pharmaceuticals Updates Share Capital and Voting Rights Structure
2M ago
Hemogenyx Raises £118,632 Through Warrant Exercise and Expands Share Capital
Premium
Company Announcements
Hemogenyx Raises £118,632 Through Warrant Exercise and Expands Share Capital
2M ago
Hemogenyx Raises £2.5m to Advance CAR-T Trials in Adult and Pediatric AML
Premium
Company Announcements
Hemogenyx Raises £2.5m to Advance CAR-T Trials in Adult and Pediatric AML
3M ago
More GB:HEMO News >

HEMO News on the Web

Hemogenyx Files Annual FDA IND Report as AML CAR‑T Trial Shows Early Promise
TipRanks News
Neutral
Hemogenyx Advances HG-CT-1 CAR-T Program With Manufacturing Transfer and Trial Expansion
TipRanks News
Neutral
Hemogenyx Pharmaceuticals Updates Share Capital and Voting Rights Structure
TipRanks News
Neutral
Hemogenyx Raises £118,632 Through Warrant Exercise and Expands Share Capital
TipRanks News
Neutral
Hemogenyx Raises £2.5m to Advance CAR-T Trials in Adult and Pediatric AML
TipRanks News
Neutral
Hemogenyx Raises £2.5m to Advance AML CAR-T Trials and Reduce Costs
TipRanks News
Neutral
Hemogenyx Confirms Updated Share Capital and Voting Rights
TipRanks News
Neutral
Hemogenyx shares rise after safety board backs next trial phase for CAR-T therapy
Proactive Investors
Neutral

News Score - Last 7 Days

Neutral
GB:HEMO
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:HEMO’s Media Buzz Sentiment?
1 articles about GB:HEMO were published this week. In an average week, 1 articles are published.
    What is GB:HEMO’s weekly average amount of articles?
    In an average week, 1 articles about GB:HEMO are published.
      What is GB:HEMO’s News Sentiment?
      50% of articles about GB:HEMO were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week